Specnova, an ingredient supplier specializing in liposomal technology, announced that its liposomal ashwagandha ingredient NooGandha has been granted a U.S. patent, which covers the novel composition, preparation process, and cognitive support applications of the nutraceutical, highlighting its distinctive bioactive profile and advanced delivery system.

“This patent is a major scientific and commercial milestone,” said Sebastian Balcombe, MS, Specnova founder, CEO, and medicinal chemist. “It validates years of research and development that went into optimizing a powerful, fast-acting, and clinically proven form of ashwagandha, targeted specifically for improved cognitive health and performance.”

The patent covers a unique extract composition comprising a specific spectrum of bioactive compounds, which are linked to ashwagandha’s neurological and adaptogenic benefits. These compounds are concentrated and standardized through the company’s proprietary, multi-phase extraction process that enhances efficacy while decreasing unwanted sedative effects.

The process involves drying, powdering, dual-phase solvent extraction, and a combination of root and leaf fractions, followed by purification and liposomal encapsulation to dramatically enhance bioavailability and targeted delivery.

NooGandha is backed by three randomized, double-blind, peer-reviewed studies. The most recent study, published in Nutrients, found that a single 225 mg dose of NooGandha was linked to improvements in measures of executive function, picture recall, word memory, and reaction time in healthy young adults, with further improvements after 30 days of continued use. The study also showed a reduction in measures of tension and fatigue among those who took the supplement.

NooGandha is formulated to deliver a clean, potent, and scientifically validated way to optimize mental performance. While traditional ashwagandha products often emphasize relaxation and sleep, NooGandha is designed to offer cognitive benefits without drowsiness.

“NooGandha is the only ashwagandha ingredient specifically formulated and patented for cognitive performance,” said Balcombe. “We’re delivering what today’s consumers demand: targeted efficacy, measurable outcomes, and formulation flexibility.”